Xinyue Zhou
About Xinyue Zhou
Xinyue Zhou is a Scientist I at BeiGene in China, with a background in biotechnology and animal sciences.
Title
Xinyue Zhou holds the position of Scientist I at BeiGene in China. Her current role involves significant responsibilities in biotechnological applications and upstream process development.
Company
Xinyue Zhou is currently employed at BeiGene, a global biotechnology company. BeiGene focuses on developing innovative and affordable therapies to fight cancer. As a Scientist I, Zhou plays a crucial role in the company's scientific research and development efforts.
Education and Expertise
Xinyue Zhou achieved her Master's degree in Biotechnology from Northeastern University, where she studied from 2018 to 2020. She also holds a Bachelor's degree in Animal Sciences from Southwest University, completed between 2013 and 2017. Additionally, she spent 11 months at the University of Minnesota Duluth in 2017. Her academic background provides a strong foundation in both biotechnology and animal sciences, enhancing her expertise in upstream process development and bioprocessing techniques.
Professional Background
Before joining BeiGene, Xinyue Zhou gained valuable experience at Entrada Therapeutics in Boston, Massachusetts. She worked as a Research Associate in 2021 for six months, and earlier as an Upstream Co-op for five months in 2020. At Entrada Therapeutics, she focused on upstream process development and scaling up bioreactor operations, contributing to optimizing bioprocesses for increased efficiency and yield.
Bioprocessing and Research Experience
Xinyue Zhou has an extensive background in both academic and industrial settings, allowing her to contribute to various biotechnological applications effectively. She has participated in multiple research projects focused on developing novel bioprocessing techniques. Her expertise in upstream process development, particularly in scaling up bioreactor operations, reflects her ability to optimize bioprocesses to enhance efficiency and yield. This diverse experience makes her a valuable asset in the field of biotechnology.